Scribe Therapeutics Inc. (SCTX)

Scribe Therapeutics will go public soon, but the exact IPO date is still unknown.

Stock Price: Pending

IPO price not available yet

Scribe Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Cash & Equivalents	20.38	12.8	12.6
Short-Term Investments	29.35	45.17	92.57
Cash & Cash Equivalents	49.73	57.96	105.17
Cash Growth	-	-44.89%	-
Receivables	1.28	7.09	3.12
Other Current Assets	1.39	1.88	2.09
Total Current Assets	52.4	66.93	110.37
Property, Plant & Equipment	-	7.01	9.63
Goodwill and Intangibles	-	3.06	3.55
Other Long-Term Assets	-	1.21	4.42
Total Long-Term Assets	-	11.29	17.6
Total Assets	-	78.22	127.97
Accounts Payable	-	4.57	3.79
Deferred Revenue	-	21.09	23.41
Current Debt	-	36.62	1.12
Other Current Liabilities	79.72	6.78	6.71
Total Current Liabilities	79.72	69.06	35.02
Long-Term Debt	-	4.8	40.56
Other Long-Term Liabilities	-	27.42	57.89
Total Long-Term Liabilities	-	32.23	98.46
Total Liabilities	-	101.28	133.47
Total Debt	46.33	41.43	41.68
Debt Growth	-	-0.60%	-
Retained Earnings	-	-157.71	-135.9
Comprehensive Income	-	0.04	0.07
Shareholders' Equity	-158.74	-143.42	-125.86
Net Cash (Debt)	3.4	16.54	63.49
Net Cash (Debt) Growth	-	-73.96%	-
Working Capital	-27.32	-2.12	75.36